Department of Thyroid and Endocrinology, Fukushima Medical University School of Medicine, Fukushima 960‑1295, Japan.
Department of Coloproctology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Fukushima 969‑3492, Japan.
Mol Med Rep. 2017 Nov;16(5):7367-7374. doi: 10.3892/mmr.2017.7553. Epub 2017 Sep 20.
Inhibitor of growth 2 (ING2) is involved in chromatin remodeling and it has previously been suggested that ING2 may regulate gene expression. The authors previously identified matrix metalloproteinase 13 (MMP13) as a target gene of ING2 in colorectal cancer. The aim of the present study was to identify novel genes regulated by ING2 and histone deacetylase 1 (HDAC1) and to clarify the biological significance of the ING2 structure. The present study generated the point mutant constructs of ING2 and deletion constructs consisting of partial ING2 to investigate the effect on gene expression and verify the interaction with HDAC1, mSin3A and sap30. A microarray was performed to find novel ING2/HDAC1 target genes using cell co‑overexpression of ING2 and HDAC1. Plasminogen activator inhibitor‑1 (PAI‑1) was upregulated with overexpression of ING1b and ING2. The mutation of the PHD domain at 218 significantly attenuated the MMP13 and PAI‑1 expression, whereas the mutation at 224 resulted in increased expression. Furthermore, the expression levels were slightly reduced by the mutation of the C‑terminal. The lack of the PHD domain and the C‑terminal in ING2 resulted in a decreased ability to induce gene expression. The C‑terminal with PHD domain, which lacked the N‑terminal, maintained the transactive function for regulating the target genes. In addition to MMP13 and PAI‑1, eight genes [heat shock protein family A member 1A (HSPA1A), MIR7‑3 host gene, chorionic somatomammotropin hormone 1, growth arrest and DNA damage inducible b, dehydrogenase/reductase 2, galectin 1, myosin light chain 1, and VGF nerve growth factor inducible] were demonstrated to be associated with ING2/HDAC1. The present study demonstrated that ING2/HDAC1 regulated PAI‑1 and HSPA1A expression and the PHD domain and the C‑terminal of ING2, which are binding sites of HDAC1 and mSin3A, are essential regions for the regulation of gene expression.
抑生长因子 2(ING2)参与染色质重塑,先前有研究表明 ING2 可能调节基因表达。作者先前发现基质金属蛋白酶 13(MMP13)是结直肠癌中 ING2 的靶基因。本研究旨在鉴定受 ING2 和组蛋白去乙酰化酶 1(HDAC1)调控的新基因,并阐明 ING2 结构的生物学意义。本研究构建了 ING2 的点突变构建体和包含 ING2 部分缺失的缺失构建体,以研究其对基因表达的影响,并验证与 HDAC1、mSin3A 和 sap30 的相互作用。通过细胞共转染 ING2 和 HDAC1 进行微阵列分析,以寻找 ING2/HDAC1 的新靶基因。PAI-1 在 ING1b 和 ING2 的过表达下上调。在 218 位 PHD 结构域的突变显著减弱了 MMP13 和 PAI-1 的表达,而在 224 位突变则导致表达增加。此外,C 端的突变导致表达水平略有降低。ING2 中 PHD 结构域和 C 端的缺失导致诱导基因表达的能力降低。缺乏 N 端的 PHD 结构域和 C 端保持调节靶基因的转录活性功能。除了 MMP13 和 PAI-1 之外,还鉴定了另外 8 个基因 [热休克蛋白家族 A 成员 1A(HSPA1A)、MIR7-3 宿主基因、绒毛膜生长催乳素激素 1、生长停滞和 DNA 损伤诱导 b、脱氢酶/还原酶 2、半乳糖凝集素 1、肌球蛋白轻链 1 和 VGF 神经生长因子诱导]与 ING2/HDAC1 相关。本研究表明,ING2/HDAC1 调节 PAI-1 和 HSPA1A 的表达,ING2 的 PHD 结构域和 C 端是 HDAC1 和 mSin3A 的结合位点,是调节基因表达的必需区域。